Free 7-day Trial
All Articles and Columns »

Baron Funds Comments on Questcor Pharmaceuticals Inc.

December 07, 2012 | About:
Todd Sullivan

Shares of Questcor Pharmaceuticals, Inc. (QCOR) were the biggest detractor in the quarter.The company sells a single drug for which it has expanded applications to drive rapid growth. Our research uncovered some red flags which led us to sell out of our position in the quarter. Subsequent to our exit, the stock fell significantly, so I credit our work and instinct for avoiding a bigger loss.

From Baron Funds third quarter letter.


Rating: 2.0/5 (5 votes)

Comments

Please leave your comment:


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide